Zobrazeno 1 - 4
of 4
pro vyhledávání: '"O M Peiro Ibanez"'
Autor:
A Carrasquer Cucarella, A Bardaji Ruiz, I Fort Gallifa, O M Peiro Ibanez, V Del Moral Ronda, G Bonet Pineda, N Lal-Trehan Estrada, R Sanchez Gimenez
Publikováno v:
European Heart Journal. 42
Background Diabetes and myocardial injury are clinical conditions associated with cardiovascular events and increased mortality during follow-up. It is not known to what extent both conditions enhance their prognostic effect in patients seen in the e
Autor:
M I Gonzalez Del Hoyo, K Vaquez-Nunez, J. I. Rodriguez, M Ferrero, Gil Bonet, Alfredo Bardají, A Romeu, F Dominguez Benito, O M Peiro Ibanez, Anna Carrasquer
Publikováno v:
European Heart Journal. 41
Introduction The standard modifiable cardiovascular risk factors (SMuRFs), like diabetes mellitus, hyperlipidemia,hypertension and smoking, are central elements of the well-established European Society of Cardiology SCORE calculator. However, acute c
Autor:
Verónica Quintern, O M Peiro Ibanez, Sergio Rojas, J Ordonez, Alfredo Bardají, A Garcia, Gil Bonet
Publikováno v:
European Heart Journal. 40
Introduction Biomarkers plays a critical role in diagnostic, prognostication, and decision-making in cardiovascular medicine. Growth differentiation factor-15 (GDF-15) has been reported as a potential biomarker in acute coronary syndrome (ACS). Howev
Autor:
Alfredo Bardají, Sergio Rojas, Verónica Quintern, Gil Bonet, A Garcia, O M Peiro Ibanez, Jordi Ordóñez-Llanos, Núria Farré
Publikováno v:
European Heart Journal. 40
Introduction After an acute coronary syn bdrome (ACS) patients are at high risk of cardiovascular morbidity and mortality. In this scenario, Growth differentiation factor-15 (GDF-15) and Stromal cell derived factor-1 (SDF-1) has been reported as pote